Evaluation of Pharmaceutical Intervention at Hepatitis C Medication Therapy Adherence Clinic in North Borneo, Malaysia (Epic MTAC)

Authors

  • Bee Keng Law Department of Pharmacy, Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia
  • Euginie Tracy Wong Department of Pharmacy, Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia
  • Qiao Wei Liew Department of Pharmacy, Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia
  • Zhi Sam Heng Department of Pharmacy, Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia

DOI:

https://doi.org/10.51200/bjms.v14i.2318

Keywords:

pharmacist, hepatitis C, pharmaceutical intervention, Medication Therapy Adherence Clinic (MTAC), Sustained Virological Response (SVR)

Abstract

Introduction: Hepatitis C virus (HCV) is a worrying public health issue worldwide. The introduction of direct-acting antiviral agents (DAAs) brings revolution to HCV treatment. Pharmacists’ role in Malaysia is significant since the implementation of Medication Therapy Adherence Clinic (MTAC). This study aims to determine the sustained virological response (SVR12) for HCV patients treated with Sofosbuvir and Daclatasvir and/or Ribavirin. Besides, it evaluates adherence rate, types of pharmaceutical intervention and physicians’ acceptance rate.

Published

2020-03-30

How to Cite

Law, B. K., Wong, E. T., Liew, Q. W., & Heng, Z. S. (2020). Evaluation of Pharmaceutical Intervention at Hepatitis C Medication Therapy Adherence Clinic in North Borneo, Malaysia (Epic MTAC). Borneo Journal of Medical Sciences (BJMS), 14, 9. https://doi.org/10.51200/bjms.v14i.2318
Total Views: 254 | Total Downloads: 0 | Total Downloads: 141